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The observed higher GDP-tubulin binding affinity could be a result of a faster on-rate and/or slower off-rate from GDP-tubulin. To further explore tau's nucleotide preference we photobleached Alexa488-tau on different regions of the microtubule and measured the fluorescence recovery after photobleaching (FRAP) ( Figure 1D ). As seen in Figure 1E , fluorescence recovery occurred faster on GMPCPP seeds as compared to GDP-tubulin extensions. Under the experimental conditions, recovery is determined by the off-rate constant 12 , and thus tau has a higher off-rate from GMPCPP-tubulin than for GDP-tubulin. Furthermore, the fold difference is approximately equal to the observed fold shift in affinity.
Therefore, we conclude that tau's increased affinity for GDP-tubulin is a result of a reduced unbinding rate constant.
Tau is less abundant at the growing end of microtubules in vitro
Since GMPCPP is an analog of GTP, it is possible that tau merely prefers GMPCPP and binds to microtubule-bound GTP-tubulin with similar or even greater affinity to that of tau binding to GDP-tubulin. If tau indeed prefers GDP-over GTP-tubulin, then it should be absent from the tip of growing microtubules, the exact opposite of the characteristic EB enrichment on the tips of growing microtubules. To test if this was the case, we tracked the end of dynamic microtubules using our previously published tracking procedure 13, 14 and quantified the average fluorescence along the microtubule axis. To improve tracking precision, the rhodamine-tubulin ratio was reversed such that 15% of the tubulin in solution was labeled (Figure 2A ). This labeling reversal did not influence the observation of tau enrichment on GDP-extensions versus GMPCPP seeds ( Figure 2B ). As seen in Figure 2C , the leading edge of tau fluorescence, on average, lagged behind the leading edge of tubulin fluorescence leading to a statistically significant (p < 0.001) offset of 78 nm ± 15 nm (median ± 95% CI) between the two during periods of growth. This observation is consistent with tau having lower affinity to the stabilizing cap of GTP-tubulin as compared to regions of GDP-tubulin proximal to the microtubule tip. The offset is also consistent with previous estimates of the stabilizing cap size in vitro 5, 15 .
As the microtubule grows, and tubulin subunits are added to the microtubule lattice, it will necessarily take time for tau to bind to newly created binding sites. If the rate of tau on-off kinetics are slow compared to site creation, then tau binding will lag behind the growing end.
Therefore, it is feasible that the observed offset is simply a result of tau on-off kinetics, as opposed to a binding preference for GDP-tubulin. To test which model is more consistent with experimental observations, we simulated tau's association dynamics with the microtubule under the two different models ( Figure 2D ). In the simple kinetic model ( Figure 2D top) , tau is allowed to bind to any site on the microtubule with uniform affinity. Here, tau's simulated off-rate and binding affinity was equal to that measured experimentally for microtubule extensions (Figure 1 ). In the second model, nucleotide preferential binding ( Figure 2D bottom), tau's on-rate was uniform for all sites on the microtubule but the off-rate for GTP-tubulin was based on the faster rate observed for GMPCPP seeds experimentally ( Figure 1E -F). To compare simulation output to experimental measurements, we used model convolution 16 to simulate resulting tubulin and tau images, which were then processed through the same tip tracking algorithm in order to estimate any potential offset between the tau and tubulin fluorescence. We found that the simple kinetic model predicted a smaller offset compared to the nucleotide preference model during periods of growth that was quantitatively smaller than the offset observed experimentally ( Figure 2E ). In the nucleotide preference model, increasing the tau concentration from 300 nM to 1 µM, closer to the K D of GMPCPP-tubulin (or GTP-tubulin in the model), resulted in a slightly decreased offset ( Figure 2E ). This was a result of tau's increased binding to regions of GTPtubulin at the microtubule tip. In the simple kinetic model, the offset was not influenced by the tau concentration, although this simply reflects the low offset initially at 300 nM. The observed offset in the nucleotide preference model was predicted to be eliminated during periods of shortening ( Figure 2F) . Thus, the model predicts that if tau indeed binds to GTP-tubulin with similar affinity to that of the analog GMPCPP-tubulin, then an experimental offset during growth should be of similar magnitude and be reduced by an increase in tau concentration.
Furthermore, any potential offset should be lost during shortening. We tested the model predictions in our in vitro assay in the presence of 300 nM and 1 µM Alexa488-tau. As seen in Figure 2G , tau moderately increased the growth rate in vitro, similar to previous observations 8 . Because EB comet size (or GTP cap size) is proportional to the rate of growth 17 , this adds a potential complication to the analysis at a single tubulin concentration.
For example, if microtubules grow faster in the presence of 1 µM tau compared to 300 nM or no tau, then the GTP cap size will be larger, thereby increasing the potential offset in a nucleotide preference model. Therefore, we compensated for this effect on growth rate by adjusting the tubulin concentration in the presence of tau such that the average microtubule growth rate was equal across all conditions ( Figure 2H ). Experimentally, we found that the offset in the presence of 300 nM tau was comparable to that predicted from the nucleotide preference model, but quantitatively inconsistent with the simple kinetic model ( Figure 2I ). Additionally, as predicted by the nucleotide preference model, the experimental offset decreased in the presence of 1 µM tau compared to 300 nM. The experimental shortening rate was reduced with increasing tau concentrations ( Figure 2J ), suggestive of a stabilizing effect of tau. As predicted by the nucleotide model, the observed fluorescence offset during growth was lost during periods of shortening ( Figure 2K ). Thus, experimental offset trends were qualitatively and quantitatively consistent with the nucleotide preference model and inconsistent with the simple kinetic model.
In summary, the simple kinetic model is incapable of producing an offset comparable to that observed experimentally. Therefore, we conclude that tau is offset from the microtubule plusend due to preferentially binding GDP-tubulin over GTP-tubulin in vitro.
Tau is a microtubule tip avoider in mammalian cells
To determine if tau exhibits a nucleotide preference in living cells we transiently expressed human 2N4R tau tagged with EGFP along with mCherry-α-tubulin in LLC-PK1 mammalian cells.
While these cells are not neuronal, they provide multiple advantages over neurons. First, they form expansive, thin regions where single microtubules are readily visible and are ideal for nanoscale quantitative analysis 18 . Additionally, since epithelial cells do not natively express tau, all tau in the cells should be tagged with EGFP. We found that tau-EGFP was expressed at variable levels and that it was localized to microtubules ( Figure 3A ). Additionally, tau-EGFP exhibited binding characteristics consistent with those previously observed 11 We expect that if tau is acting as a microtubule tip avoider, then it should exhibit the opposite characteristics; it will be offset from the microtubule plus end during growth but not shortening, and this offset should be positively correlated with the rate of microtubule growth. Consistent with a tip avoider, we observed a separation of the tubulin signal from that of tau-EGFP during periods of growth in cells co-expressing tau-EGFP and mCherry-α-tubulin ( Figure 3B , white arrow). This visible offset subsequently disappeared during periods of shortening ( Figure 3B , cyan arrow). To further quantify this observation, we performed the same tau and tubulin fluorescence profile analysis used in vitro in the LLC-PK1 cells, and compared it to the fluorescence profile of EB1. As seen in Figure 3C , tau was, on average, offset from the plus end of the microtubule in vivo during periods of growth. Interestingly, the initial drop in tau-EGFP fluorescence was directly aligned with the initial rise in EB1-EGFP fluorescence ( Figure   3C ). Additionally, we found that the average offset (226 ± 38 nm; mean ± 95% CI) was consistent with our previous estimates of the GTP cap size in the same cells, 750 GTP-tubulin subunits or 310 nm 5 . During periods of shortening, the tau and tubulin fluorescence converged such that there was no longer an offset ( Figure 3D ), as observed in the kymographs. In vivo, microtubules exhibit a much wider range of growth rates compared to in vitro. To further test our hypothesis, we binned microtubules by growth rate and plotted their rate versus average fluorescence offset. Consistent with the prediction for a tip avoider, fluorescence offset was directly correlated with growth rate, increasing for faster growing microtubules ( Figure 3E ). Furthermore, an offset during shortening was not detected and was not correlated with rate of shortening. As a result of being absent from the microtubule plus end during growth, we did not observe any effect of tau-EGFP expression on microtubule growth rate or catastrophe frequency ( Figure 3F ). While we did not observe an offset trend with respect to growth in vitro ( Figure S2A ), this was likely a result of the narrow range of growth rates observed in vitro compared to in vivo. The overall trend of net rate versus offset in vitro was comparable to that observed in vivo ( Figure S2B ). Based on these results, we conclude that tau acts as a microtubule tip avoider, absent from the microtubule plus-end, in mammalian cells.
Tau offset in vivo is consistent with a preferential binding model
Unlike in vitro, it is possible that other MAPs in LLC-PK1 cells interfere or compete with tau for binding sites, resulting in the observed offset in tau fluorescence from the microtubule plus end. EB1, in particular, could be such a competitor as it binds preferentially to the microtubule plus end during growth and is expressed at high concentrations 5 . To test whether a competitive binding model could be consistent with experimental observations in vivo, we first quantified the tau-EGFP binding kinetics. FRAP of tau bound to regions of the microtubule resulted in an estimated off-rate constant of 2.02 s -1 ( Figure 4A ), consistent with that estimated for GDP microtubules in vitro. To construct a tau binding curve, we estimated the amount of tau-EGFP bound per length of microtubule using our previous approach for quantifying EB1 concentrations in the same cells 5 . All regions analyzed were proximal to the microtubule plus end (i.e. towards the minus end) and presumably consisted of GDP-tubulin. We found that tau-EGFP bound to microtubules with K D = 1.1 µM, which was qualitatively higher than our estimate for GDP-tubulin in vitro, although not statistically significant due to the uncertainty in the in vivo measurement.
From these estimates we constructed a computational model for in vivo tau binding kinetics similar to the in vitro model ( Figure 2C-D) . In addition to the simple kinetic model and nucleotide preference model, we constructed a third model where EB1 and tau compete for binding sites ( Figure 4D ). Values used for EB1 kinetics and concentration were from our previous estimates in these cells 5 . We found that the only model consistent with in vivo experimental observations of tau binding was the nucleotide preference model ( Figure 4F-G) . Neither the simple model nor the competitive binding model were able to predict experimental observations of the tau fluorescence offset ( Figure 4F ). Additionally, simulated images obtained through model convolution of the model output 16 showed that the nucleotide preference model resulted in microtubule tip avoider behavior, where a distinguishable separation between tau and tubulin fluorescence was detectable during growth ( Figure 4G , white arrows) and subsequently absent during shortening ( Figure 4G , cyan arrows), consistent with experimental observations in the presence of tau ( Figure 3B ). This visible offset was not seen in either the simple model or the competitive binding model. Based on these observations, we conclude that tau acts as a microtubule tip avoider in vivo by preferentially binding GDP-tubulin over GTPtubulin.
Discussion:
By performing high resolution, quantitative fluorescence measurements of tau binding to microtubules in vitro and in vivo we show here that tau avoids the GTP cap at the growing end of microtubules, resulting in an offset or lag of tau at the growing plus end. Additionally, the size of this offset is positively correlated with the microtubule growth rate, the exact opposite of +TIP tracking proteins. We find that these observations are consistent with a nucleotide preference model, in which tau preferentially binds unstable GDP-tubulin over the more stable form of GTPtubulin. To our knowledge, the evidence that we show here is the first example of a MAP that preferentially binds GDP-tubulin, thereby functioning as a growing microtubule tip avoiding protein.
One interesting potential benefit to being a tip avoiding MAP is that tau could influence microtubule dynamics specifically during shortening, thus perhaps controlling the extent of microtubule loss during shortening without interfering with the dynamics of growth and catastrophe. This would allow microtubule plus ends to continue to dynamically explore the intracellular space while controlling the extent of large-scale losses of polymer mass that can occur during the shortening phase. It is interesting to speculate that this capability would allow neuronal microtubule plus ends to dynamically grow into and shorten from axonal branches and dendritic spines without risking large scale depolymerization-mediated microtubule polymer loss from axons and dendrites.
Tau has long been believed to act as a microtubule stabilizer and promote microtubule bundling in axons, although the stabilizing role of tau has recently been challenged 19 . The aberrant regulation of tau phosphorylation states causes it to dissociate from microtubules and self-associate, forming neurofibrillary tangles characteristic of tauopathies such as Alzheimer's disease and dementia. It is possible that tau hyperphosphyorylation and/or mutation in these neurological diseases exert their phenotype by their failure to properly recognize GDP-tubulin.
The vast majority of tubulin in microtubules is GDP-bound, and such a loss of function would significantly shift the distribution of tau in neurons. Furthermore, more tau would be available to bind to GTP-tubulin, thus displacing +TIPs, such as EB3, and their associated activities into abnormal locations in the neuron.
One remaining question, however, is what is the specific mechanism by which tau distinguishes the tubulin nucleotide states? Recently, cryo-EM has shown the structural differences of GDPand GTP-tubulin in the microtubule lattice, specifically that GTP-tubulin undergoes a compaction at the longitudinal interface upon nucleotide hydrolysis 20 . This compaction likely leads to a change in the intradimer distance between tubulin subunits, where tau binds to the microtubule 21 , that is energetically favorable to tau binding. This could also explain observations that tau preferentially binds curved regions of microtubules 11 , where the intradimer distance will be reduced on the inside of the microtubule curves compared to straight regions.
Furthermore, preliminary data suggests that tau's nucleotide binding preference is specific to tubulin in microtubules and is not present when binding to tubulin in solution ( Figure S3 ). Thus, it appears that a possible explanation for tau's nucleotide preference is that it is reading out the structural changes in the microtubule lattice structure that are a result of hydrolysis.
Materials and Methods:

Tau cloning, purification, and labeling
The parent tau plasmid encodes for the longest tau isoform, 2N4R tau. It includes an N-terminal His-tag with a tobacco etch virus (TEV) protease cleavage site for purification 22 . The native cysteines, C291 and C322, are mutated to serine to allow for the introduction of cysteine at residue S433 for site-specific labeling. This mutation does not impact microtubule polymerization in vitro 23 . Site specific labeling of tau for fluorescent measurements was carried out as described previously 22 . Briefly, tau was incubated with 1 mM dithiolthreitol (DTT) for 30 minutes, and then buffer exchanged into labeling buffer (20 mM Tris pH 7.4, 50 mM NaCl, and 6 M guanidine HCl).
Alexa Fluor 488 maleimide was added in 2-fold molar excess and incubated at room temperature for 10 minutes, followed by overnight incubation at 4°C. Labeling reactions were protected from ambient light and with constant stirring; the dye was added dropwise. The labeled protein was buffer exchanged into 20 mM Tris pH 7.4 and 50 mM NaCl and unreacted dye was removed using HiTrap Desalting Columns (GE Life Sciences). Labeled protein was then snap frozen for storage at -80°C. The addition of Alexa488 did not influence tau-induced tubulin polymerization overall ( Figure S4 ).
Preparation and functionalization of imaging chambers
Imaging chambers for TIRF microscopy were assembled and functionalized as described in 24 , with few modifications. First, an acid cleaned coverslip 25 was rendered hydrophobic by brief incubation in Rain-X® Original Glass Water Repellent (ITW Global Brands, Houston TX) at room temperature. Coverslips were then allowed to dry completely before remaining residue was wiped away using lens paper. Hydrophobic coverslips were then mounted to acid cleaned glass slides using double sided tape, forming three separate imaging channels.
Imaging chambers were functionalized by flowing in solutions of 0.1 mg/mL NeutrAvidin (ThermoFischer Scientific, Waltham, MA) in PBS, followed by 5% Pluronic® F-127 (Sigma-Aldrich, St. Louis, MO) in PBS, and then doubly stabilized GMPCPP microtubule seeds (5% or 15% rhodamine-labeled, 5% biotin-labeled) in BRB80 (80 mM PIPES/KOH pH 6.9, 1 mM EGTA, 1 mM MgCl 2 ). For each separate solution, chambers were allowed to incubate at room temperature for 10 mins and then washed with 8-10x chamber volume of BRB80. After the last wash, 2x chamber volumes of the imaging solution was flowed through the imaging chamber before moving to the microscope for imaging. Imaging solution consisted of indicated concentration of porcine brain tubulin (5% or 15% rhodamine-labeled, Cytoskeleton Inc., Denver CO) and Alexa488-labeled tau in BRB80 supplemented with 1 mM GTP, 40 mM D-glucose, 8 µg/mL catalase, 20 µg/mL glucose-oxidase, and 0.1 mg/mL casein. To prevent sample drying during imaging, individual imaging chambers were sealed using CoverGrip sealant (Biotium, Fremont, CA).
TIRF microscopy
Unless otherwise noted, all proteins were handled and stored as described previously 24 .
Rhodamine-labeled microtubules growing from double-stabilized GMPCPP microtubule seeds were imaged by TIRF microscopy using a 100x, 1.49NA Apo TIRF objective on a Nikon TiE Rochester, NY) was focused on the imaging plane as previously described 18 using a separate light path from that used for TIRF imaging. Bleach event timing was set to a 3 s delay and 100 ms exposure using a VMM-TI shutter driver/timer (Vincent Associates). Simultaneous TIRF imaging was accomplished by replacing the triple band pass filter above with an 80/20 beam splitter. To compensate for the beam splitter, the 488 nm TIRF laser was increased to 100% power such that 20% laser power used for imaging was maintained. Temperature was maintained at 37°C using an objective heater (OkoLab S.R.L., Pozzuoli, Italy) and airstream incubator (Nevtek, Burnsville, VA).
Live cell imaging
LLC-PK1 cells used for imaging were cultured in glass-bottomed 35 mm dishes as previously 
Tau binding simulations
In vitro and in vivo microtubule assembly dynamics were simulated as previously described 18 , using the pseudomechanical model 26 . Since the tau binding profile was the simulation output of interest, microtubule dynamics simulations were run prior to and independent of tau binding simulations. Tau on-off kinetics were simulated for all subunits in the microtubule lattice based the probability of tau binding or unbinding as determined by p = 1-exp(-k*t), where k is tau's onrate (k * on = k on *[tau]) or off-rate (k off = k on *K D ; K D is tau's affinity for the microtubule) and t is the current time step from the microtubule simulation. After determining the on-off probabilities, a random number, r i , was generated for each individual subunit and the event was executed if r i < p. The execution order for binding and unbinding was randomly determined at each time step, t.
For the simple kinetic model, it was assumed that tau kinetics were equivalent for all sites on the microtubule. For the nucleotide preference model, tau's off-rate was determined by the nucleotide state of the tubulin subunit that it was associated with; here k off,T = k on *K D,T , k off,D = k on *K D,D , and K D,D < K D,T . EB1 binding kinetics were handled in the same manner as tau using concentration and K D values estimated previously 5 . For the competitive binding model, tau and EB1 binding was not permitted to sites already occupied by either protein. To quantify fluorescence offset, simulation output was model convolved 16 based on the experimental imaging setup to create simulated fluorescence images. These model convolution images were then run through the same analysis scheme used for experimental images. All simulations were carried out in MATLAB R2017a (The Mathworks Inc, Natick, MA).
Microtubule tip tracking and fluorescence profile analysis
The dynamic microtubule end was tracked using our previously described semi-automated algorithm 13, 14 , TipTracker (version 3.1), without modification. Briefly, fluorescence profiles along the determined microtubule axis (x''-axis) are fit with a Gaussian survival function
where µ PF is taken to be the position of the microtubule tip, I MT and I BG are the fluorescence intensity on the microtubule and the background, respectively, and σ PF+PSF is the spread of the fluorescence due to the combination of the point spread function and the taper or spread of protofilament lengths at the microtubule tip. For averaging purposes, fluorescence profiles along the microtubule axis from all channels (tubulin, tau, and EB1) were aligned to µ PF determined from the tubulin channel (either rhodamine-tubulin or mCherry-α-tubulin).
Fluorescence offset values were the difference between µ PF resulting from tracking the tubulin and tau channels (offset = µ PF,tub -µ PF,tau ). In vitro fluorescence profiles were normalized to the maximum value while in vivo profiles were normalized to an average of the first 10 values.
For the current imaging setup, the fluorescence intensity per EGFP molecule per exposure was determined using LLC-PK1α cells stably expressing EGFP-α-tubulin 27 as previously described 5 .
This value was then used to estimate the number of tau molecules bound per length of microtubule by dividing the integrated fluorescence by the length of the microtubule segment.
Since LLC-PK1 cells are epithelial and do not express tau, it was assumed that all tau molecules in the cells expressing tau-EGFP were tagged.
FRAP curves were fit with an exponential recovery curve by weighting early time points during recovery more strongly than steady-state values as described previously 18 . Prior to fitting, FRAP values were corrected using microtubules outside the bleached region and then normalized to the average value over 2 s (20 frames) prior to the bleach event. Assuming the tau dynamics are at steady-state with microtubules in vitro and in vivo, and that the amount of bleached tau is small compared to the total amount of tau, then the exponential recovery is dictated by the off-rate as described in 12 ;
where k off is the tau unbinding rate.
Statistical analysis
Unless otherwise noted, comparisons between experimental conditions were performed by oneway analysis of variance (ANOVA) statistical tests performed in MATLAB (R2017a) using the anova1 function, and where appropriate, corrected for multiple comparisons using the multcompare function. For all statistics, 95% confidence intervals were estimated using a bootstrapping method as previously described 18 . Error bars are ± 95% CI. Fluorescence offset value indicated is the median ± 95% CI. D) Simulated tau binding models.
In a simple kinetic model (top), tau binds and unbinds from all sites independent of nucleotide state. In the nucleotide preference model, tau's off-rate constant is higher for GTP-tubulin A competitive binding model in which tau competes with EB1 for sites along the length of microtubule. Tau is not allowed to bind to sites occupied by EB1 (k on,wEB = 0). EB1 binds with higher affinity to GTP-tubulin compared to GDP-tubulin, which gives it microtubule plus end tracking ability. E) A nucleotide preference model in which tau binds with higher affinity to GDPtubulin compared to GTP-tubulin. As in the competitive model, tau is not allowed to bind to sites occupied by EB1. F) Model-predicted offset as a function of the simulated tau kinetics. Error bars are ± 95% CI. G) Simulated images of tubulin (red) and tau (green) fluorescence signal resulting from the models in C and E. Microtubule dynamics were simulated using the in vivo parameters from 18 . White and cyan arrows identify periods of growth and shortening, respectively.
